We are live on ! Find out more
PTX

Pernix Therapeutics Holdings, Inc.
PTX

Delisted

PTX was delisted on the 4th of March, 2019.

104 hedge funds and large institutions have $135M invested in Pernix Therapeutics Holdings, Inc. in 2015 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 42 increasing their positions, 34 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

24% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 34

9% less funds holding

Funds holding: 114104 (-10)

35% less capital invested

Capital invested by funds: $209M → $135M (-$73.1M)

42% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 24

95% less call options, than puts

Call options by funds: $24K | Put options by funds: $506K

Holders
104
Holders Change
-10
Holders Change %
-8.77%
% of All Funds
2.9%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
14
Increased
42
Reduced
34
Closed
24
Calls
$24K
Puts
$506K
Net Calls
-$482K
Net Calls Change
+$106K
Name Holding Trade Value Shares
Change
Change in
Stake
Royal Bank of Canada
76
Royal Bank of Canada
Ontario, Canada
$71K -$205K -4,290 -65%
Barclays
77
Barclays
United Kingdom
$68K +$58.6K +1,225 +119%
Invesco
78
Invesco
Georgia
$60K -$34.6K -724 -28%
VKH
79
Virtu KCG Holdings
New York
$60K +$90.3K +1,888 New
PCM
80
Prelude Capital Management
New York
$51K +$69.1K +1,444 +926%
JMPWA
81
JP Morgan Private Wealth Advisors
California
$48K +$72.6K +1,518 New
ECP
82
Empyrean Capital Partners
California
$47K
GC
83
Guggenheim Capital
Illinois
$46K +$20.9K +436 +43%
CS
84
Credit Suisse
Switzerland
$45K -$1.21M -25,287 -95%
US Bancorp
85
US Bancorp
Minnesota
$38K -$10K -210 -15%
Morgan Stanley
86
Morgan Stanley
New York
$34K -$66.1K -1,382 -57%
RFC
87
Russell Frank Company
Washington
$34K -$25.7K -538 -33%
MC
88
Menta Capital
California
$34K +$51.2K +1,070 New
BNP Paribas Financial Markets
89
BNP Paribas Financial Markets
France
$32.1K +$31.3K +655 +181%
TRCT
90
Tower Research Capital (TRC)
New York
$17K -$40.4K -845 -61%
Legal & General Group
91
Legal & General Group
United Kingdom
$17K
BJ
92
BlackRock Japan
Japan
$17K +$26.4K +551 New
Simplex Trading
93
Simplex Trading
Illinois
$14K +$1.1K +23 +5%
Citigroup
94
Citigroup
New York
$12K -$41.2K -861 -68%
CSS
95
Cubist Systematic Strategies
Connecticut
$8K +$12.6K +263 New
QT
96
Quantbot Technologies
New York
$7K -$27.7K -580 -71%
LTFS
97
Ladenburg Thalmann Financial Services
Florida
$6K -$18.2K -380 -67%
BlackRock
98
BlackRock
New York
$3K
TWA
99
TCI Wealth Advisors
Arizona
$3K
AWM
100
Avior Wealth Management
Nebraska
$2K

PTX Hedge Fund Activity: Q3 2015 in Review

104 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Pernix Therapeutics Holdings, Inc. (PTX) for Q3 2015, worth a combined $135M — down 35% from $209M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of PTX and 14 opened new positions — a net loss of 10 holders — while 34 trimmed existing stakes and 42 added.

The largest buyer was Armistice Capital, opening a new position worth an estimated $23M. The largest seller was Janus Henderson Investors US, exiting entirely with an estimated $14.8M sold.

  • 104 institutional investors held Pernix Therapeutics Holdings, Inc. (PTX) as of Q3 2015, down from 114 in Q2 2015.
  • Funds reported $135M of Pernix Therapeutics Holdings, Inc. stock for Q3 2015, down 35% quarter-over-quarter.
  • 14 funds opened new Pernix Therapeutics Holdings, Inc. positions in Q3 2015 and 24 closed out, a net change of -10 holders.
  • The largest Pernix Therapeutics Holdings, Inc. buyer in Q3 2015 was Armistice Capital, an estimated $23M added.
  • The largest Pernix Therapeutics Holdings, Inc. seller in Q3 2015 was Janus Henderson Investors US, an estimated $14.8M sold.

Based on aggregated 13F filings for Q3 2015.